Galeno Desenvolvimento de Pesquisas Clínicas
Quick facts
Marketed products
- Lidocaine + Prilocaine · Anesthesia/Pain Management
Lidocaine and prilocaine are local anesthetics that block sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.
Phase 3 pipeline
- ethinyl estradiol + levonorgestrel + folic acid · Contraception / Women's Health
This combination oral contraceptive suppresses ovulation through progestin and estrogen activity while folic acid supplementation reduces neural tube defect risk in pregnancy.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Galeno Desenvolvimento de Pesquisas Clínicas portfolio CI brief
- Galeno Desenvolvimento de Pesquisas Clínicas pipeline updates RSS
Frequently asked questions about Galeno Desenvolvimento de Pesquisas Clínicas
What are Galeno Desenvolvimento de Pesquisas Clínicas's marketed drugs?
Top marketed products include Lidocaine + Prilocaine.
What is Galeno Desenvolvimento de Pesquisas Clínicas's pipeline?
Galeno Desenvolvimento de Pesquisas Clínicas has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include ethinyl estradiol + levonorgestrel + folic acid.
Related
- Lidocaine + Prilocaine · Anesthesia/Pain Management
- Sector hub: All tracked pharma companies